Top Markets
#1 Nesa Nesa +719.78%
#2 EXOD EXOD +22.78%
#3 Pons Pons +14.63%
#4 MetaDAO MetaDAO +13.02%
#5 Venom Venom +11.05%
#6 Status Status +9.00%
#7 PondCoin PondCoin +8.44%
#8 Wrapped NXM Wrapped NXM +7.88%
#9 Prom Prom +7.75%
#10 Ontology Gas Ontology Gas +7.38%
Coin of the day
Nesa Nesa
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Rang in Aktien #3185
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Aktienkurs
$10.35
Marktkapitalisierung
$6.19B
Veränderung (1 Tag)
3.79%
Veränderung (1 Jahr)
4.34%
Land
CN
Handel Gan & Lee Pharmaceuticals. (603087)

Kategorie

Healthcare
P/S-Verhältnis für Gan & Lee Pharmaceuticals. (603087)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Gan & Lee Pharmaceuticals. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Gan & Lee Pharmaceuticals. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
12.63 -
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
2.55 -
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
- -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
2.43 -
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
- -
CH